Emerging Therapy Solutions® (ETS) provides payers with end-to-end solutions to manage cell and gene therapies and transplants and is the only company solely focused on this complex and rapidly evolving space, leveraging 30+ years of experience managing transplants. We’re the leading resource
for hundreds of payers, employers and the brokers and consultants who advise them, as well as stop-loss and reinsurance carriers—providing unmatched expertise that translates into greater foresight, savings, and peace of mind. ETS CGT360 solutions include proactive patient identification and navigation, population data analysis, Centers of Excellence network access with preferred rates, comprehensive clinical tools, and more. Learn more at emergingtherapies.com.